Patrick J. Loehrer

26.2k total citations · 6 hit papers
362 papers, 18.6k citations indexed

About

Patrick J. Loehrer is a scholar working on Oncology, Surgery and Neurology. According to data from OpenAlex, Patrick J. Loehrer has authored 362 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Oncology, 124 papers in Surgery and 101 papers in Neurology. Recurrent topics in Patrick J. Loehrer's work include Myasthenia Gravis and Thymoma (72 papers), Testicular diseases and treatments (58 papers) and Neuroblastoma Research and Treatments (42 papers). Patrick J. Loehrer is often cited by papers focused on Myasthenia Gravis and Thymoma (72 papers), Testicular diseases and treatments (58 papers) and Neuroblastoma Research and Treatments (42 papers). Patrick J. Loehrer collaborates with scholars based in United States, Kenya and Canada. Patrick J. Loehrer's co-authors include Lawrence H. Einhorn, Stephen D. Williams, Robert J. Mayer, Leonard B. Saltz, Justin Kopit, Neal J. Meropol, Michael N. Needle, Craig R. Nichols, F. Anthony Greco and Robert Birch and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Patrick J. Loehrer

345 papers receiving 18.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

2004 1.4k citations Patrick J. Loehrer et al. Journal of Clinical Oncology profile →
Cisplatin

1984 861 citations Patrick J. Loehrer et al. profile →
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

1987 825 citations Stephen D. Williams, Lawrence H. Einhorn et al. profile →
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

1992 752 citations Patrick J. Loehrer, Lawrence H. Einhorn et al. Journal of Clinical Oncology profile →
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer

1998 685 citations Patrick J. Loehrer, George Wilding et al. profile →
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

2011 604 citations Patrick J. Loehrer, Yang Feng et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Patrick J. Loehrer

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Loehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Loehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Loehrer more than expected).

Fields of papers citing papers by Patrick J. Loehrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Loehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Loehrer. The network helps show where Patrick J. Loehrer may publish in the future.

Co-authorship network of co-authors of Patrick J. Loehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Loehrer. A scholar is included among the top collaborators of Patrick J. Loehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Loehrer. Patrick J. Loehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global Equity in Clinical Trials: A Pragmatic Approach 2025 ·JCO Global Oncology ·(unknown), Jennifer Morgan, (unknown), Abraham Siika, Patrick J. Loehrer, Naftali Busakhala	1
2	Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya 2025 ·JCO Global Oncology ·Naftali Busakhala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Patrick J. Loehrer, Lameck Diero, Jennifer Morgan	1
3	Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO 2024 ·JCO Global Oncology ·María T. Bourlon, Ami S. Bhatt, Gilberto Lopes, Fredrick Chite Asirwa, Alexandru Eniu, Patrick J. Loehrer, Lawrence N. Shulman, Julia Close, Jamie Von Roenn, (unknown), Doug Pyle, Julie R. Gralow	1
4	Enteric adenocarcinoma of the Thymus 2023 ·American Journal of Clinical Pathology ·(unknown), (unknown), Hector Mesa, Patrick J. Loehrer	0
5	Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors 2023 ·JCO Precision Oncology ·(unknown), Bryan P. Schneider, Sandra K. Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, (unknown), Patrick J. Loehrer	4
6	LEEP more effective than cryotherapy as effective treatment for CIN lesions in women living with HIV and without HIV in western Kenya (2129) 2023 ·Gynecologic Oncology ·(unknown), Omenge Orang’o, Ann Mwangi, (unknown), Tao Liu, Edwin Sang, (unknown), (unknown), Patrick J. Loehrer, Susan Cu‐Uvin	0
7	Low sensitivity of the careHPV™ Assay for detection of Oncogenic Human Papillomavirus in cervical samples from HIV-infected and HIV-uninfected Kenyan women 2020 ·eCommons - AKU (Aga Khan University) ·(unknown), Aaron Ermel, Ann M. Moormann, Susan Cu‐Uvin, Omenge Orang’o, (unknown), Kiprotich Chelimo, Barry P. Rosen, (unknown), (unknown), Patrick J. Loehrer, (unknown), (unknown)	0
8	Recommendations from the ASCO Academic Global Oncology Task Force 2020 ·JCO Global Oncology ·Julie R. Gralow, Fredrick Chite Asirwa, Ami S. Bhatt, María T. Bourlon, Quyen D. Chu, Alexandru Eniu, Patrick J. Loehrer, Gilberto Lopes, Lawrence N. Shulman, Julia Close, Jamie Von Roenn, (unknown), Doug Pyle	11
9	Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies 2019 ·Lung Cancer ·Jessica A. Hellyer, Matthew A. Gubens, Kristen Cunanan, Sukhmani K. Padda, Matthew Burns, Aaron John Spittler, Jonathan W. Riess, (unknown), Kavitha Ramchandran, Joel W. Neal, Heather A. Wakelee, Patrick J. Loehrer	11
10	A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas 2016 ·PMC ·Milan Radovich, Jeffrey P. Solzak, Bradley A. Hancock, (unknown), (unknown), (unknown), Jin Zhu, Jarret Glasscock, Kenneth A. Kesler, Sunil Badve, Bryan P. Schneider, Patrick J. Loehrer	3
11	Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies 2015 ·Journal of Thoracic Disease ·Heather A. Wakelee, Sukhmani K. Padda, Matthew Burns, Aaron John Spittler, Jonathan W. Riess, (unknown), Kavitha Ramchandran, Matthew A. Gubens, Joel W. Neal, Patrick J. Loehrer	1
12	NUT midline carcinomas in the thymic region 2014 ·Modern Pathology ·Yesim Gökmen‐Polar, (unknown), Kenneth A. Kesler, Patrick J. Loehrer, Sunil Badve	8
13	Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial breakdown → 2011 ·Journal of Clinical Oncology ·Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes, Lynne I. Wagner, Joanna M. Brell, David Cella, Patrick J. Flynn, Ramesh K. Ramanathan, Christopher H. Crane, Steven R. Alberts, Al B. Benson	604
14	WHO types A and AB thymomas: not always benign 2010 ·Modern Pathology ·Rohit Jain, Rutika Mehta, John Henley, Kenneth A. Kesler, Patrick J. Loehrer, Sunil Badve	33
15	Sacrococcygeal teratoma in adults 1999 ·Cancer ·Elizabeth W. Ng, Pierluigi Porcu, Patrick J. Loehrer	60
16	5-Fluorouracil and Leucovorin Therapy in Patients With Hormone Refractory Prostate Cancer 1998 ·American Journal of Clinical Oncology ·Jordan Berlin, Kathleen J. Propert, Donald L. Trump, George Wilding, Gary R. Hudes, John H. Glick, Patrick A. Burch, Alan Keller, Patrick J. Loehrer	20
17	The Year book of oncology 1989 ·Bulletin of Miscellaneous Information (Royal Gardens Kew) ·Robert C. Young, Joseph V. Simone, Robert F. Ozols, Patrick J. Loehrer, J.T. Thigpen, R.J. Arceci	1
18	Ifosfamide in testicular cancer: the Indiana University experience. 1989 ·PubMed ·Patrick J. Loehrer, Stephen D. Williams, Lawrence H. Einhorn	10
19	Etoposide and Split-Dose Cisplatin in Bronchogenic Carcinoma 1988 ·American Journal of Clinical Oncology ·Richard C. Lauer, William B. Fisher, Kenneth Pennington, Rafat Ansari, Lawrence H. Einhorn, Patrick J. Loehrer	3
20	Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor 1986 ·Journal of Thoracic and Cardiovascular Surgery ·Patrick J. Loehrer, Isidore Mandelbaum, Siu Hui, Steven A. Clark, Lawrence H. Einhorn, Stephen D. Williams, John P. Donohue	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact